Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Neumora Therapeutics Inc....

    NASDAQ: NMRA · Real-Time Price · USD
    0.84
    -0.02 (-2.73%)
    At close: Jun 17, 2025, 12:38 PM

    Neumora Therapeutics Common Stock Statistics

    Share Statistics

    Neumora Therapeutics Common Stock has 161.75M shares outstanding. The number of shares has increased by 1.54% in one year.

    Shares Outstanding

    n/a
    		 161.75M

    Shares Change (YoY)

    n/a
    		 1.54%

    Shares Change (QoQ)

    n/a
    		 0.26%

    Owned by Institutions (%)

    n/a
    		 49.08%

    Shares Floating

    n/a
    		 65.21M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,652

    FTD / Avg. Volume

    n/a
    		 0.36%

    Short Selling Information

    The latest short interest is 15.02M, so 9.29% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 15.02M

    Short % of Shares Out

    n/a
    		 9.29%

    Short % of Float

    n/a
    		 25.66%

    Short Ratio (days to cover)

    n/a
    		 18.94

    Valuation Ratios

    The PE ratio is -6.93 and the forward PE ratio is -0.78. Neumora Therapeutics Common Stock's PEG ratio is -2.58.

    PE Ratio

    n/a
    		 -6.93

    Forward PE

    n/a
    		 -0.78

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 5.89

    P/FCF Ratio

    n/a
    		 -9.23

    PEG Ratio

    n/a
    		 -2.58
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Neumora Therapeutics Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.51, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 10.51

    Quick Ratio

    n/a
    		 10.51

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,216,245.45

    Employee Count

    n/a
    		 110

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 178K

    Effective Tax Rate

    n/a
    		 -0.07%

    Stock Price Statistics

    The stock price has increased by -90.72% in the last 52 weeks. The beta is 2.74, so Neumora Therapeutics Common Stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.74

    52-Week Price Change

    n/a
    		 -90.72%

    50-Day Moving Average

    n/a
    		 0.75

    200-Day Moving Average

    n/a
    		 5.92

    Relative Strength Index (RSI)

    n/a
    		 53.31

    Average Volume (20 Days)

    n/a
    		 1,026,525

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -263.46M

    Net Income

    n/a
    		 -243.79M

    EBITDA

    n/a
    		 -242.98M

    EBIT

    n/a
    		 -243.61M

    Earnings Per Share (EPS)

    n/a
    		 -1.53
    Full Income Statement

    Balance Sheet

    The company has 142.15M in cash and 1.85M in debt, giving a net cash position of 140.29M.

    Cash & Cash Equivalents

    n/a
    		 142.15M

    Total Debt

    n/a
    		 1.85M

    Net Cash

    n/a
    		 140.29M

    Retained Earnings

    n/a
    		 -947.22M

    Total Assets

    n/a
    		 256.75M

    Working Capital

    n/a
    		 226.48M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -182.94M and capital expenditures 0, giving a free cash flow of -182.94M.

    Operating Cash Flow

    n/a
    		 -182.94M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -182.94M

    FCF Per Share

    n/a
    		 -1.15
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NMRA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NMRA is $5, which is 474.7% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 474.7%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.57

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist